Results 11 to 20 of about 95,261 (258)

MDM2-BCL-XL PROTACs enable degradation of BCL-XL and stabilization of p53

open access: yesActa Materia Medica, 2022
Inhibition or degradation of the anti-apoptotic protein BCL-XL is a viable strategy for cancer treatment. Despite the recent development of PROTACs for degradation of BCL-XL, the choice of E3 ligase has been restricted to VHL and CRBN.
Mengyang Chang   +4 more
doaj   +3 more sources

ΔN-Bcl-xL, a therapeutic target for neuroprotection

open access: yesNeural Regeneration Research, 2017
The B-cell lymphoma-extra large (Bcl-xL) is a mitochondrial anti-apoptotic protein that plays a role in neuroprotection. However, during excitotoxic stimulation, Bcl-xL undergoes caspase-dependent cleavage and produces a fragmented form, ΔN-Bcl-xL ...
Han-A Park, Elizabeth A Jonas
doaj   +3 more sources

Nutritional Regulators of Bcl-xL in the Brain [PDF]

open access: yesMolecules, 2018
B-cell lymphoma-extra large (Bcl-xL) is an anti-apoptotic Bcl-2 protein found in the mitochondrial membrane. Bcl-xL is reported to support normal brain development and protects neurons against toxic stimulation during pathological process via its roles ...
Han-A Park   +4 more
doaj   +3 more sources

Advances in Bcl-xL Research 2.0

open access: yesInternational Journal of Molecular Sciences, 2023
Apoptosis is a form of programmed cell death that is highly conserved in metazoan organisms, where it ensures the proper development and homeostasis of tissues [...]
Joann Kervadec, Muriel Priault
openaire   +2 more sources

Anti‐apoptotic protein BCL‐XL as a therapeutic vulnerability in gastric cancer

open access: yesAnimal Models and Experimental Medicine, 2023
Background New therapeutic targets are needed to improve the outcomes for gastric cancer (GC) patients with advanced disease. Evasion of programmed cell death (apoptosis) is a hallmark of cancer cells and direct induction of apoptosis by targeting the ...
Yumin Wei   +11 more
doaj   +1 more source

Differential dependence on Beclin 1 for the regulation of pro-survival autophagy by Bcl-2 and Bcl-xL in HCT116 colorectal cancer cells. [PDF]

open access: yesPLoS ONE, 2010
Autophagy is described to be involved in homeostasis, development and disease, both as a survival and a death process. Its involvement in cell death proceeds from interrelationships with the apoptotic pathway.
Muriel Priault   +5 more
doaj   +1 more source

Targeting Bcl-xL is a potential therapeutic strategy for extranodal NK/T cell lymphoma

open access: yesiScience, 2023
Summary: Extranodal natural killer/T cell lymphoma, nasal type (ENKTL) is an aggressive lymphoid malignancy with a poor prognosis and lacks standard treatment. Targeted therapies are urgently needed.
Chuanxu Liu   +15 more
doaj   +1 more source

Bcl-xL Inhibitor ABT-737 Reveals a Dual Role for Bcl-xL in Synaptic Transmission [PDF]

open access: yesJournal of Neurophysiology, 2008
A role for BCL-xL in regulating neuronal activity is suggested by its dramatic effects on synaptic function and mitochondrial channel activity. When recombinant BCL-xL is injected into the giant presynaptic terminal of squid stellate ganglion or applied directly to mitochondrial outer membranes within the living terminal, it potentiates synaptic ...
John A, Hickman   +3 more
openaire   +2 more sources

Bcl-xL: A Focus on Melanoma Pathobiology

open access: yesInternational Journal of Molecular Sciences, 2021
Apoptosis is the main mechanism by which multicellular organisms eliminate damaged or unwanted cells. To regulate this process, a balance between pro-survival and pro-apoptotic proteins is necessary in order to avoid impaired apoptosis, which is the cause of several pathologies, including cancer.
Anna Maria Lucianò   +3 more
openaire   +2 more sources

DT2216—a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas [PDF]

open access: yesJournal of Hematology & Oncology, 2020
Abstract Background Patients with advanced T cell lymphomas (TCLs) have limited therapeutic options and poor outcomes in part because their TCLs evade apoptosis through upregulation of anti-apoptotic Bcl-2 proteins. Subsets of TCL cell lines, patient-derived xenografts (PDXs), and primary patient samples depend on Bcl-xL for survival.
Yonghan He   +15 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy